CompletedNot Applicable

Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy

China150 participantsStarted 2025-01-07

Plain-language summary

To observe the sedative effect of using dexmedetomidine nasal spray combined with remimazolam for pediatric bronchoscopy diagnosis and treatment, provide a safer and more comfortable anesthesia plan for pediatric bronchoscopy diagnosis and treatment

Who can participate

Age range2 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 2-6 years old (24\~72 months); * ASA I-II; * sign the informed consent. Exclusion Criteria: * Severe rhinitis, nasal deformity; * abnormal liver and kidney function; * severe dehydration, severe malnutrition, hypoproteinemia or anaemia Hb \<10 g/dl; * children with neurological disease; * history of allergy to the study drug; * recent participation in other clinical studies.

What they're measuring

Sedation success rate

Timeframe: 1day

Trial details

NCT IDNCT06755996

SponsorTongji Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Fiberoptic Bronchoscopy trials